Immunoregulatory T cells, LFA-3 and HLA-DR in autoimmune thyroid diseases

Indian Journal of Endocrinology and Metabolism

Volumn 18, Issue 4, 2014, Pages 574-581

  Nada, Aml Mohamed ^a   Hammouda, Maha ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b University of Mounofyia   (Egypt)

Author keywords

Autoimmune; CD25; CD4; CD8; Graves' disease; Hashimoto's; HLA DR; LFA 3; thyroid; Treg

Indexed keywords

EID: 84995803019     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.137524     Document Type: Article

References (63)

1. Armengol MP, Sabater L, Fernandez M, Ruiz M, Alonso N, Otero MJ, et al. Influx of recent thymic emigrants into autoimmune thyroid disease glands in humans. Clin Exp Immunol 2008;153:338-50.
2. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-7.
3. Graca L, Chen TC, Le Moine A, Cobbold SP, Howie D, Waldmann H. Dominant tolerance: Activation thresholds for peripheral generation of regulatory T cells. Trends Immunol 2005;26:130-5.
4. Davidson A, Diamond B. General features of autoimmune diseases. In: Rose E, Mackay R, editors. The autoimmune diseases. St Louis, MO: Academic Press; 2006. p. 25-36.
5. Rapoport B, McLachlan SM. Thyroid autoimmunity. J Clin Invest 2001;108:1253-9.
6. Weetman P, Rose R. Thyroid disease. In: Rose E, Mackay R, editors. The autoimmune diseases. St Louis, MO: Academic Press; 2006. p. 467-82.
7. Tait KF, Gough SC. The genetics of autoimmune endocrine disease. Clin Endocrinol 2003;59:1-11.
8. Weetman P. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 2004;61:405-13.
9. Duntas LH. Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 2008;4:454-60.
10. Tomer Y. Genetic susceptibility to autoimmune thyroid disease: Past, present, and future. Thyroid 2010;20:715-25.
11. Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000;85:536-9.
12. Barbesino G, Chiovato L. The genetics of Hashimotos disease. Endocrinol Metab Clin North Am 2000;29:357-74.
13. Sarantopoulos S, Lu L, Cantor H. Qa-1 restriction of CD8+suppressor T cells. J Clin Invest 2004;114:1218-21.
14. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, et al. Thymus and autoimmunity: Production of CD25+CD4+naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999;162:5317-26.
15. Wallich R, Brenner C, Brand Y, Roux M, Reister M, Meuer S. Gene structure, promoter characterization, and basis for alternative mRNA splicing of the human CD58 gene. J Immunol 1998;160:2862-71.
16. Wang JH, Smolyar A, Tan K, Liu JH, Kim M, Sun ZY, et al. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell 1999;97:791-803.
17. Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology. J Autoimmun 2008;30:58-62.
18. Clinical and Laboratory Standards Institute (formerly NCCLS). Procedures for the Handling and Processing of Blood Specimens; Approved Guideline. 3rd ed. Wayne PA: Clinical and Laboratory Standards Institute; 2004. NCCLS Document H18-A3.
19. Kaplan MM. Thyroid function testing in patients with thyroid and non-thyroid diseases. Mono: Thyroid Testing; Chiron Diagnostics Corporation; 1996.
20. Kaplan MM. Thyroid function testing in patients with thyroid and non-thyroid diseases. Mono: Thyroid Testing; Chiron Diagnostics Corporation; 1996.
21. Holmes KL, Otten G, Yokoyama WM. Flow cytometry analysis using the Becton Dickinson FACS Calibur. Curr Protoc Immunol 2002;Chapter 5:Unit 5.4.
22. Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res 2011;31:721-31.
23. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001;167:1245-53.
24. de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004;172:6435-43.
25. Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+T cells. Clin Immunol 2005;115:10-8.
26. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 2006;117:289-300.
27. Mao C, Wang S, Xiao Y, Xu J, Jiang Q, Jin M, et al. Impairment of regulatory capacity of CD4+CD25+Regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves disease. J Immunol 2011;186:4734-43.
28. Gambineri E, Torgerson T, Ochs H. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003;15:430-5.
29. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002;39:537-45.
30. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010;11:7-13.
31. Toubi E.Targeting T regulatory cells in autoimmune diseases. Isr Med Assoc J 2008;10:73-6.
32. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008;8:523-32.
33. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007;13:423-31.
34. Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010;10:849-59.
35. Medical Immunology. In: Virella G, editor. 6th ed. Charleston, South Carolina, New York, USA: Medical University of South Carolina; 2007.
36. Iwona BS, Jadwiga SS, Elzbieta K, Leszek S. Lymphocytes in peripheral blood and thyroid tissue in children with Graves disease. Pediatrics 2008;121:S103-4.
37. Arao T, Morimoto I, Kakinuma A, Ishida O, Zeki K, Tanaka Y, et al. Thyrocyte proliferation by cellular adhesion to infiltrating lymphocytes through the intercellular adhesion molecule-1/ lymphocyte function-associated antigen-1 pathway in Graves disease. J Clin Endocrinol Metab 2000;85:382-9.
38. Tandon N, Makgoba MW, Gahmberg CG, Weetman AP. The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells. J Clin Endocrinol Metab 1983;56:2.
39. Walter U, Santamaria P. CD8+T cells in autoimmunity. Curr Opin Immunol 2005;17:624-31.
40. Thielemans C, Vanhaelst L, De Waele M. Autoimmune thyroiditis: A condition related to a decrease in T-suppressor cells. Clin Endocrinol 1981;15:259-63.
41. Xia N, Zhou S, Liang Y, Xiao C, Shen H, Pan H, et al. CD4+T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves ophthalmopathy. Int J Mol Med 2006;17:911-6.
42. Thielemans C, Vanhaelst L, De Waele M. Autoimmune thyroiditis: A condition related to a decrease in T-suppressor cells. Clin Endocrinol 1981;15:259-63.
43. Iwatani Y, Amino N, Hidaka Y, Kaneda T, Ichihara K, Tamaki H, et al. Decreases in ? T cell receptor negative T cells and CD8 cells, and an increase in CD4+CD8+cells in active Hashimotos disease and subacute thyroiditis. Clin Exp Immunol 1992;87:444-9.
44. Iwatani Y, Amino N, Mori H, Asari S, Izumiguchi Y, Kumahara Y, et al. T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab 1983;56:251-4.
45. Bonnyns M, Bentin J, Devetter G, Duchateau J. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: Influence of thyroid status. Clin Exp Immunol 1983;52:629-34.
46. Pender MP. CD8+T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis 2012;2012:189096.
47. Reinherz EL, Weiner HL, Hauser SL. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med 1980;303:125-9.
48. Veys EM, Hermanns P, Goldstein G, Kung P, Schindler J, Van Wauwe J. Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. Int J Immunopharmacol 1981;3:313-9.
49. Morimoto C, Reinherz EL, Schlossman SF, Schur PH, Mills JA, Steinberg AD. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Investig 1980;66:1171-4.
50. Thielemans C, Vanhaelst L, De Waele M. Autoimmune thyroiditis: A condition related to a decrease in T-suppressor cells. Clin Endocrinol 1981;15:259-63.
51. Berrih S, Gaud C, Bach MA, Le Brigand H, Binet JP, Bach JF. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin Exp Immunol 1981;45:1-8.
52. Kreuzfelder E, Shen G, Bittorf M, Scheiermann N, Thraenhart O, Seidel D, et al. Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls. Eur Neurol 1992;32:190-4.
53. Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan JH. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 1982;128:351-4.
54. Moreno-Otero R, Civeira MP, Suou T, Kanof ME, James SP, Jones EA. Reduced numbers of CD8+T cells and B cell expression of Leu-8 antigen in peripheral blood of patients with primary biliary cirrhosis. Hepatogastroenterology 1994;41:239-43.
55. Covas MI, Esquerda A, Garca-Rico A, Mahy N. Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease. J Investig Allergol Clin Immunol 1992;2:131-5.
56. Clementi M, Forabosco P, Amadori A, Zamarchi R, De Silvestro G, Di Gianantonio E, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995;1:1279-83.
57. Ferreira MA, Hottenga JJ, Warrington NM, Medland SE, Willemsen G, Lawrence RW, et al. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am J Hum Genet 2010;86:88-92.
58. Ehlers M, Thiel A, Bernecker C, Porwol D, Papewalis C, Willenberg HS, et al. Evidence of a combinedcytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimotos Thyroiditis. J Clin Endocrinol Metab 2012;97:1347-54.
59. Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol 2013;5:45-9.
60. Iwatani Y, Amino N, Mori H, Asari S, Izumiguchi Y, Kumahara Y, et al. lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Investig Allergol Clin Immunol 1992;2:131-5.
61. Yoshikawa N, Morita T, Arreaza G, Resetkova E, Mukuta T, Volpé R. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease. Clin Invest Med 1995;18:91-8.
62. Gessl A, Waldhäusl W. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves disease and autoimmune thyroiditis: Discordant effect of methimazole on HLA-DR and CD69. Clin Immunol Immunopathol 1998;87:168-75.
63. Toubi E. Targeting T regulatory cells in autoimmune diseases MD. Clin Immunol Immunopathol 1992;64:30-5.